SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-330322
Filing Date
2018-11-19
Accepted
2018-11-19 16:36:00
Documents
11
Period of Report
2018-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d659634d8k.htm 8-K 16094
2 EX-99.1 d659634dex991.htm EX-99.1 19940
3 EX-99.2 d659634dex992.htm EX-99.2 10411
4 EX-99.3 d659634dex993.htm EX-99.3 11619
5 EX-99.4 d659634dex994.htm EX-99.4 8602
6 EX-99.5 d659634dex995.htm EX-99.5 20701
7 EX-99.6 d659634dex996.htm EX-99.6 22939
8 EX-99.7 d659634dex997.htm EX-99.7 22371
9 EX-99.8 d659634dex998.htm EX-99.8 8769
10 GRAPHIC g659634g06z06.jpg GRAPHIC 15429
11 GRAPHIC g659634g96u90.jpg GRAPHIC 5570
  Complete submission text file 0001193125-18-330322.txt   171902
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14710 | Film No.: 181192914
SIC: 2834 Pharmaceutical Preparations